The HLA-Cw6 antigen has been associated with psoriasis vulgaris despite racial and ethnic differences. However, it remains unclear whether it is the HLA-Cw6 antigen itself or a closely linked, hitherto unidentified, locus that predisposes to the disease. Here, in order to map the susceptibility locus for psoriasis vulgaris precisely within the HLA class I region, 11 polymorphic microsatellite markers distributed throughout a 1060 kb segment surrounding the HLA-C locus were subjected to association analysis in Japanese psoriasis vulgaris patients. Statistical analyses of the distribution and deviation from Hardy-Weinberg equilibrium of the allelic frequency at each microsatellite locus revealed that the pathogenic gene for psoriasis vulgaris is located within a reduced interval of 111 kb spanning 89-200 kb telomeric of the HLA-C gene. In addition to three known genes, POU5F1, TCF19 and S, this 111 kb fragment contains four new, expressed genes identified in the course of our genomic sequencing of the entire HLA class I region. Therefore, these seven genes are the potential candidates for susceptibility to psoriasis vulgaris.
INTRODUCTION
Psoriasis vulgaris (MIM 177900) is a common skin disorder characterized by inflammatory cell infiltration and hyperproliferation of epidermal cells. The familial nature of this disease, which affects almost 2% of Caucasian populations, has long been recognized. However, in the Japanese population, a lower incidence (0.1%) has been observed, with most psoriasis vulgaris cases being sporadic. These facts define psoriasis vulgaris as a multifactorial disease, triggered by the involvement of some environmental factors in individuals with a particular genetic background. In fact, recent genome-wide linkage studies have identified several susceptibility loci on chromosomes 6p21.3 [human leucocyte antigen (HLA)], 17q25, 4q and many others (1) (2) (3) (4) .
Among them, the HLA locus is believed to be one of the major genetic factors predisposing to disease. It is well known that psoriasis vulgaris is associated with several serologically defined HLA class I antigens such as HLA-B13, -B17, -B39, -B57, -Cw6 and -Cw7. This has been verified throughout the world, within many different populations, including Caucasians and Japanese (5) (6) (7) (8) (9) . Among these alleles, the single most consistent and significant association is that of HLA-Cw6. However, this association is not as strong as that between HLA-B27 and ankylosing spondylitis (MIM 106300), where up to 100% of patients carry the allele which most probably is the bona fide causative element (10) . Indeed, only 10% (Japanese) to 45% (Caucasians) of patients with psoriasis vulgaris carry the HLACw6 allele (6, 11) . Therefore, the possibility clearly exists that the HLA-C gene itself is not the primary locus responsible for psoriasis vulgaris and that other gene(s) located nearby harbor the true pathogenic mutation/allele, in strong linkage disequilibrium with HLA-Cw6. In this respect, fine mapping of this putative susceptibility locus using high resolution genetic markers around the HLA-C gene is clearly needed.
We recently have accomplished sequence analysis of the entire 1.8 Mb HLA class I region from MICB (major histocompatibility complex class I chain-related gene B) to HLA-F and have identified >40 new genes within this segment (12) (13) (14) . Concentrating on our target fragment, a total of 11 novel highly polymorphic microsatellite markers located at regular intervals in the region surrounding HLA-C were selected for high resolution mapping of the putative major histocompatibility complex (MHC)-linked 'psoriasis gene'.
RESULTS
During the course of our large-scale genomic sequencing, 758 microsatellite loci ranging from di-to penta-nucleotide repeats were identified within the 1.8 Mb HLA class I region, which extends from the centromeric MICB gene to the telomeric HLA-F gene (12) (13) (14) (15) and hence includes the HLA-B and -C genes. Among these microsatellites, 70 were characterized for their polymorphism content in the Japanese population. Of these, 38 were found to be highly informative with a PIC (polymorphism content) value of 0.66 and an average of 8.9 alleles (15, 16) . Here, we have selected 11 microsatellites which were densely distributed at a resolution of one microsatellite per~1 00 kb around the HLA-C locus (C1_2_A, 232 kb centromeric; C1_4_1, 91 kb centromeric; C1_2_5, 19 kb centromeric; C1_4_3, 29 kb telomeric; C1_3_1, 31 kb telomeric; C1_2_6, 89 kb telomeric; C1_3_2, 143 kb telomeric; C2_4_4, 200 kb telomeric; C4_2_12, 457 kb telomeric; C4_2_25, 618 kb telomeric; and C3_2_11, 831 kb telomeric) (Fig. 1) .
A total of 76 Japanese patients with psoriasis vulgaris were enrolled for association analysis using these microsatellites. In the patients, the phenotype frequency of HLA-Cw6 (8/76 patients, 10.5%) was significantly increased, with a Pc-value of 0.02 (odds ratio = 15.88). As shown in Table 1 , alleles showing statistically significant differences from the Pc-value of <0.05 in the patient group were found at four microsatellite loci: alleles 303 (χ 2 = 12.62, Pc = 0.0015) of C1_2_6; 357 (χ 2 = 7.91, Pc = 0.034) of C1_3_2; 255, 259 (χ 2 = 9.53, Pc = 0.012 and χ 2 = 11.58, Pc = 0.0022, respectively) of C2_4_4; and 223 (χ 2 = 7.59, Pc = 0.036) of C4_2_12. Alleles in each microsatellite marker were named on the basis of the amplified fragment size length. The most significant association was obtained for the 303 allele of the C1_2_6 locus. All four microsatellites in the segment from the loci C1_2_6 to C4_2_12 exhibited statistically significant differences in their allele frequencies between the patients and controls (Table 1 and Fig. 1 ).
The exact test of Hardy-Weinberg proportion was also carried out for these 11 microsatellite markers by the Markov chain method (17) in terms of deviation from Hardy-Weinberg proportions (the probability test) and heterozygote deficiency against the null hypothesis of Hardy-Weinberg equilibrium (18, 19) . All of the 11 markers tested followed, as expected, Hardy-Weinberg equilibrium in the healthy controls (P > 0.25). In contrast, five loci deviated significantly from Hardy-Weinberg equilibrium in the patients (P < 0.1: C1_2_5, C1_3_1, C1_2_6, C1_3_2 and C2_4_4). Furthermore, five loci showed a significant decrease in heterozygotes (P < 0.1: C1_4_3, C1_3_1, C1_3_2, C2_4_4 and C4_2_12), as listed in Table 2 . On the other hand, heterozygote excess was not observed at any markers. It must be noted that the three microsatellite loci (C1_3_1, C1_3_2 and C2_4_4) in the segment from C1_3_1 to C2_4_4 displayed significant P-values in both probability and heterozygote deficiency tests (Table 2 and Fig. 1 ). In particular, C1_3_2 and C2_4_4 reached highly significant P-values for both of these tests. In this study, to determine the definite position of the causative gene for psoriasis vulgaris within the HLA class I region, association analyses were conducted using 11 of these 38 repeats. Four of these microsatellites (C1_2_6, C1_3_2, C2_4_4 and C4_2_12) in the segment from C1_2_6 to C4_2_12 displayed statistically significant differentiation between the patients and controls (Table 1 and Fig. 1) . Further, the Hardy-Weinberg equilibrium analyses in the patient group suggested that the three microsatellite loci (C1_3_1, C1_3_2 and C2_4_4) in the segment from C1_3_1 to C2_4_4 displayed significant deviation from Hardy-Weinberg equilibrium in both the probability and heterozygote deficiency tests (Table 2 and Fig. 1 ). In particular, C1_3_2 and C2_4_4 reached highly significant P-values for both tests. Although the mode of inheritance of psoriasis is unclear, the lower than expected frequency of heterozygotes at these five microsatellite loci in the patients (Table 1 ) may suggest a recessive HLA trait for this disease, although the genetic penetrance is not high. Collectively, it can be concluded that the 111 kb segment from C1_2_6 (89 kb telomeric of HLA-C) to C2_4_4 (200 kb telomeric of HLA-C) is the common area critical for psoriasis vulgaris at a >95% confidence level, as assessed by both statistical methods for allelic distribution and deviation from Hardy-Weinberg equilibrium (Fig. 1) . It must be emphasized that these two independent statistical methods, of which the former deals with the data of patients and controls and the latter only with the data of patients, revealed an almost identical critical segment for psoriasis vulgaris. This result is consistent with previous mapping data showing that the susceptibility gene for psoriasis vulgaris resides on the telomeric side of the HLA-C gene, based on the transmission/ disequilibrium test (TDT) and parametric linkage analysis using the HLA class I (HLA-A, -B and -C) and class II (HLA-DRB1 and -DQB1) alleles in the patients (22) . Investigation of recombinant haplotypes in the HLA region revealed the presence of the five 'frozen blocks' in which recombination rarely occurs, thus maintaining stable ancestral HLA haplotypes (23) . Among them, the β-block spans~500 kb from the HLA-B-associated transcript 1 (BAT1) gene to the S gene. The telomeric boundary of this β-block, where a hotspot for genetic recombination is supposed to operate, is in the region of the C2_4_4 locus and so may also define the telomeric end of the critical region for psoriasis vulgaris.
Within this defined critical region for psoriasis vulgaris, we have so far identified three known genes, POU5F1 (OTF3; octamer transcription factor 3) (24,25), TCF19 (SC1; cell growth-regulated gene) (25, 26) and S (corneodesmosin gene) (27) (28) (29) (30) , two new, completely expressed sequence tagmatched expressed genes as well as two putative genes detected by RT-PCR (using keratinocyte mRNA). The S gene encodes a 52-56 kDa protein, corneodesmosin, which is expressed in differentiating epidermal keratinocytes. Given this, it is an obvious candidate for psoriasis vulgaris. However, our previous genetic analysis of polymorphic nucleotide positions 619 (Ser/Phe), 1240 (Gly/Val) and 1243 (Ser/Leu) failed to delineate any significant associations with the Japanese psoriasis vulgaris patients (28) . This is in contrast to a reported notable disease association with Leu (allele 2) at position 1243 in Caucasian patients (29, 30) . Although the reason for this discrepancy remains unclear at present, there are three possible explanations. First, the number of patients enrolled in our study (28) was not sufficient (n = 63) to obtain statistical significance, as compared with those in Tazi (30) . Second, there is an unknown disease-causing allele or mutation in the S gene itself or in a nearby gene, which in turn is in linkage disequilibrium with allele 2 at position 1243 in Caucasian populations, but not in the Japanese population. Third, the pathogenic gene (or allele) is not identical in Japanese and Caucasian patients, which may indeed result in the observed differential clinical manifestations between two populations, e.g. the age of disease onset, the familial clustering, the incidence, the frequency of HLA-Cw6-carrying patients, etc. POU5F1 and TCF19 are two further other genes within the critical area. POU5F1 is expressed in totipotent and pluripotent stem cells of the pregastrulation embryo and plays a role in early development (23) . The TCF19 gene is ubiquitously expressed in the G 1 -S phases of the cell cycle as a cell growth regulatory factor. Based on these broadly based functions, neither POU5F1 nor TCF19 appear to be obvious candidates for the putative MHClinked psoriasis vulgaris gene, although this needs to be ruled out formally.
One of the four new genes in the 111 kb critical region for psoriasis vulgaris is expressed in most of the tissues examined, including keratinocytes, and encodes a plectin-like protein with α-helical coiled-coil rod domains. Plectin has been proposed to provide mechanical strength to cells and tissues by acting as a cross-linking element of the cytoskeleton (31) . Furthermore, it is of particular interest that the plectin gene is responsible for the development of epidermolysis bullosa simplex (32) . The other three new genes have no homology to any known sequences in the DNA databases, although it is noteworthy that all of them are expressed specifically in keratinocytes and skin tissues. Thus, in addition to the S gene, these four new genes are also strong candidates for psoriasis vulgaris in terms of their expression pattern and/or predicted function. In this respect, it is of great importance to investigate disease-associated polymorphism(s)/mutation(s) within all these loci in several ethnically diverse patient and control populations.
MATERIALS AND METHODS

Patients
A total of 76 unrelated Japanese patients with psoriasis vulgaris and 132 healthy controls were investigated in this study. All patients were hospitalized for diagnosis and treatment at the Department of Dermatology, Tokai University School of Medicine (Kanagawa, Japan). The patient group consisted of 51 males and 25 females with mean age of onset of 33.9 years (SD = 15.3). Informed consent was obtained from all the healthy donors and patients by explaining the details of this study prior to collection of peripheral blood.
Genotyping for microsatellite alleles
To determine the number of repeat units of the microsatellite loci exhibiting polymorphisms, unilateral primers were synthesized by labeling at the 5′ end with the fluorescent reagent, 6-FAM, HEX or TET (PE Biosystems, Foster City, CA). PCR primers used for amplification of 11 microsatellites (C1_2_A, C1_4_1, C1_2_5, C1_4_3, C1_3_1, C1_2_6, C1_3_2, C2_4_4, C4_2_12, C4_2_25 and C3_2_11) are shown in Table 3 . The PCR reaction mixture contained 50 ng of genomic DNA, 2 µl of dNTP (2.5 mM each), 2 µl of 10× buffer (100 mM Tris-HCl, pH 8.3, 500 mM KCl, 15 mM MgCl 2 ) and 20 pmol of forward and reverse primers as well as 0.5 U of Takara recombinant Taq polymerase (Takara Shuzo, Kyoto, Japan) in a total volume of 20 µl. After initial denaturation for 5 min at 96°C, amplification was carried out in an automated thermal cycler (Takara Shuzo) for 30 cycles consisting of 1 min at 96°C, 30 s at 55°C and 45 s at 72°C, with a final extension of 4 min at 72°C. The amplified products were denatured for 5 min at 100°C, mixed with formamidecontaining stop buffer, applied with a size standard marker of GS500 Tamra (PE Biosystems) to each lane and run on a 4% polyacrylamide denaturing sequencing gel containing 8 M urea in an automated DNA sequencer. Fragment sizes were determined automatically using the GeneScan software (PE Biosystems).
Statistical analysis
Allele frequencies were estimated by direct counting. The significance of the distribution of alleles between the patients and the controls was tested by the χ 2 method with the continuity correction and Fisher's exact probability test (P-value test). The P-value was corrected by multiplying by the number of microsatellite alleles observed in each locus (Pc). A level of Pc < 0.05 was accepted as statistically significant. The odds ratio of the risk of psoriasis vulgaris was calculated from the 2 × 2 contingency table. The exact P-value test of the HardyWeinberg proportion for multiple alleles was simulated by the Markov chain method within the Genepop software package (15) (16) (17) . The Markov chain method has the advantage of giving a complete enumeration for testing the HardyWeinberg proportion in cases where the number of alleles as well as sample size are small. When the number of alleles was <5, the exact P-value was calculated by the complete enumeration method. A level of P < 0.1 was accepted as statistically significant for the Hardy-Weinberg equilibrium test. (Fig. 1) . Repeat units are determined from our sequencing data (14) . All markers were established by Tamiya et al. (15, 16 
